At the news
? BULLISHIMPACT 7/10 PRESS-RELEASE filed Apr 30, 2026 at 16:05 ET
Merit Medical reported Q1 2026 EPS of $0.94 (non-GAAP, the Street convention), beating the $0.83 consensus by 13.3%, and revenue of $381.9M, exceeding the $377.6M estimate by 1.1%. The company maintained its full-year 2026 guidance for revenue of $1.612-$1.634B and non-GAAP EPS of $4.01-$4.15, while organic constant-currency revenue grew 3.7% excluding a divestiture.
- Non-GAAP EPS of $0.94 beat consensus of $0.83 by 13.3%
- Revenue of $381.9M beat consensus of $377.6M by 1.1%
- Revenue grew 7.5% YoY reported; constant-currency organic growth was 2.7% (3.7% ex-divestiture)
- Non-GAAP operating margin expanded to 19.7% from 19.3% YoY
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access